David Fulper, PhD, director of technology support at Catalent, shares insights on the challenges and opportunities for cannabis-based therapeutics.
Efficient synthesis of complex cannabinoids is possible while avoiding marijuana cultivation.
Our sister publication, LCGC International, sat down with Zacariah Hildenbrand, PhD, Chief Science Officer of Infinity Water Solutions and Partner of Medusa Analytical, for more insight into various trends in cannabis testing.
Want to begin cannabis testing but don’t know where to start? Register now to find out how even somebody with no previous GC experience can start in house testing of cannabis samples. On Demand webcast available until Jan. 31, 2019.
The big challenge of supercritical CO2 extraction: the highest possible yield of the ingredients in the shortest possible time. This requires optimum, homogeneous grinding of the cannabis plant. No problem with FRITSCH technology.
States that have legalized cannabis use also have a zero tolerance workplace drug policy that usually requires a urine test of known metabolites of THC.
A goodbye letter from former Group Editorial Director, Meg L'Heureux.
An expanded list of 15 mycotoxins LC–MS/MS analysis is shown here with a simple solvent and modified QuEChERS salt extraction.
In an ever-evolving cannabis industry where regulatory compliance and accurate testing are paramount, staying ahead requires a deep understanding of how to build an efficient testing lab that meets compliance standards:
Op-ed on a new study related to how cannabidiol (CBD) exerts its clinical efficacy.
The volatility of wholesale cannabis prices marked by large fluctuations and regional disparities highlight the inherent instability still present in the cannabis marketplace. Adapting to shrinking margins and increased competitions is putting pressure on operators, causing them to adopt cost-cutting technologies, expand into edibles and extracts, and secure long-term supply agreements. Understanding these evolving dynamics is essential for companies to adapt, compete, and thrive in the industry.
Currently in the cannabis industry, the standards and benchmarks for drug delivery, analytics and testing, consumer reporting, and packaging are basic in nature with substantial room for more sophistication and technology. Here’s how it can be improved.